Skip to content

Clinical trials

Phase 2 Lymphoma, Non-Hodgkin trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 2 Country / region: Denmark Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20101
20171
20181
20192
20201
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Fred Hutchinson Cancer Center2
AstraZeneca1
Genmab1
Hoffmann-La Roche1
International Extranodal Lymphoma Study Group (IELSG)1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin11
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Mantle-Cell3
Waldenstrom Macroglobulinemia3
Burkitt Lymphoma2
Hematologic Neoplasms2
Hodgkin Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.